Literature DB >> 14692018

Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma.

Lodovico Balducci1, Lazzaro Repetto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14692018     DOI： 10.1002/cncr.11861

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  9 in total

1.  Senior adult oncology.

Authors:  Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes
Journal:  J Natl Compr Canc Netw       Date:  2012-02       Impact factor: 11.908

2.  Management Strategies for Elderly Patients with Diffuse Large B-Cell Lymphoma.

Authors:  Loretta J Nastoupil; Rajni Sinha; Christopher R Flowers
Journal:  Eur Oncol Haematol       Date:  2012-05

3.  Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies-bendamustine and G-CSF support.

Authors:  Claudio Cerchione; Amalia De Renzo; Davide Nappi; Maria Di Perna; Roberta Della Pepa; Novella Pugliese; Lucio Catalano; Fabrizio Pane; Marco Picardi
Journal:  Support Care Cancer       Date:  2019-01-23       Impact factor: 3.603

4.  Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy.

Authors:  Futoshi Iioka; Kiyotaka Izumi; Yoshimasa Kamoda; Takashi Akasaka; Hitoshi Ohno
Journal:  Int J Clin Oncol       Date:  2015-10-13       Impact factor: 3.402

5.  Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea.

Authors:  Jaekyung Cheon; Hyeon-Su Im; Ho-Jin Shin; Inho Kim; Won Sik Lee; Kyung-Hun Lee; Seong Kyu Park; Min Kyoung Kim; Un Jong Choi; Jung Han Kim; IlKyun Lee; Jae-Cheol Jo
Journal:  Support Care Cancer       Date:  2021-03-08       Impact factor: 3.603

Review 6.  Management of the toxicity of chemotherapy and targeted therapies in elderly cancer patients.

Authors:  J Feliu; V Heredia-Soto; R Gironés; B Jiménez-Munarriz; J Saldaña; C Guillén-Ponce; M J Molina-Garrido
Journal:  Clin Transl Oncol       Date:  2019-06-25       Impact factor: 3.405

Review 7.  Management of aggressive lymphoma in very elderly patients.

Authors:  Catherine Thieblemont; Sophie Bernard; Thierry Molina
Journal:  Hematol Oncol       Date:  2017-06       Impact factor: 5.271

8.  Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective.

Authors:  Roberto E Gómez; Maria L Ardigo
Journal:  Front Oncol       Date:  2012-10-29       Impact factor: 6.244

9.  Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies?

Authors:  Annamaria Ferrero; Michela Villa; Elisa Tripodi; Luca Fuso; Guido Menato
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.